The HAI Europe Association is a formal membership body of organisations and individuals that are interested in promoting access to, and the rational use of, needed medicines in the EU. It welcomes new members who wish to work collaboratively on important EU medicines policy issues.

To maintain the independence of the Association, members must not have financial ties to the pharmaceutical industry and make a declaration of interest stating they are free from conflicts of interest.

Currently, the HAI Europe Association has 121 individual and 16 organisational members in countries across Europe and beyond. For more information on the Association, and how to join, email

The HAI Europe Association Board

The HAI Europe Association Board represents members, oversees membership (admissions, resignations, financial) and coordinates an Annual General Meeting. The Board also provides content expertise on HAI’s annual work plan for European projects.

Board Governance

Governance of the HAI Europe Association is undertaken by an elected Board. HAI Europe Association members are elected to the Board at the Annual General Meeting. All members of the HAI Europe Association are eligible to stand as board members, nominate board members and vote for board membership. Board members may stand for a three-year term of office, renewable once. The Board meets twice a year in the first and last quarters. The articles of the Association also provide for the possible replacement of a current Board member in case of long-term illness or non-compliance with the statutory regulations of the Association.

A member of the HAI Foundation Board is invited to both HAI Europe Association Board meetings.

HAI Europe Association Board Members
Vanessa López
Kirsten Myhr
Dr. Mogha Mohga Kamal-Yanni